AI isn’t a Panacea in Drug Discovery — Yet
MaRS Impact Health
May
7
2025
Date: May 7, 2025
Time: 1:40PM (EST)
Location: MaRS Centre, 101 College St., Toronto, ON
Mintz Partner Anthony de Fazekas with be speaking on a panel titled "AI isn’t a Panacea in Drug Discovery — Yet," at the MaRS Impact Health Conference. The panelists will cover how AI is not a cure-all for drug discovery, but startups in the field are securing lucrative pharma deals and shifting towards developing their own drugs. Despite its potential to speed up commercialization and cut costs, challenges like data compliance, IP leakage, and complex regulations remain.
Speakers
Anthony is a go-to intellectual property attorney and strategist who advises IP-centric and data-rich companies across a range of industries. He has a particular focus on information technology, including fintech and artificial intelligence, as well as innovations at the intersection of computing technologies and health care.
Alexander Mosa
Chair and CSO of Biossil
Janet Bannister
Managing Partner of Staircase Ventures
Mobeen Lalani
Senior Analyst, Technology and Venture Development of Toronto Innovation Acceleration Partners (TIAP)